RIP3, a novel apoptosis-inducing kinase

215Citations
Citations of this article
154Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

RIP3 is a novel gene product containing a N-terminal kinase domain that shares extensive homology with the corresponding domain in RIP (receptor- interacting protein) and RIP2. Unlike RIP, which has a C-terminal death domain, and RIP2, which has a C-terminal caspase activation and recruitment domain, RIP3 has a unique C terminus. RIP3 binds RIP through its unique C- terminal segment and by virtue of this interaction is recruited to the tumor necrosis factor (TNF) receptor-1 signaling complex. Previous studies have shown that RIP mediates TNF-induced activation of the anti-apoptotic NF-κB pathway. RIP3, however, attenuates both RIP and TNF receptor-1-induced NF- κB activation. Overexpression studies revealed RIP3 to be a potent inducer of apoptosis, capable of selectively binding to large prodomain initiator caspases.

Cite

CITATION STYLE

APA

Xiaoqing, S., James, L., Navas, T., Baldwin, D. T., Stewart, T. A., & Dixit, V. M. (1999). RIP3, a novel apoptosis-inducing kinase. Journal of Biological Chemistry, 274(24), 16871–16875. https://doi.org/10.1074/jbc.274.24.16871

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free